Innophos Holdings, Inc. (NASDAQ:IPHS) was downgraded by investment analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, July 12th.

A number of other analysts have also recently commented on IPHS. Zacks Investment Research raised shares of Innophos Holdings from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th. Sidoti raised shares of Innophos Holdings from a “neutral” rating to a “buy” rating in a research report on Friday, May 26th. They noted that the move was a valuation call.

Shares of Innophos Holdings (IPHS) opened at 47.38 on Wednesday. The firm has a market capitalization of $918.98 million, a price-to-earnings ratio of 20.69 and a beta of 0.85. Innophos Holdings has a 52 week low of $37.02 and a 52 week high of $58.22. The firm has a 50-day moving average price of $43.53 and a 200-day moving average price of $47.20.

Innophos Holdings (NASDAQ:IPHS) last posted its quarterly earnings data on Tuesday, August 1st. The specialty chemicals company reported $0.57 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.05. The business had revenue of $179.14 million during the quarter, compared to the consensus estimate of $172.65 million. Innophos Holdings had a return on equity of 13.79% and a net margin of 6.46%. Innophos Holdings’s quarterly revenue was down 1.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.63 earnings per share. On average, equities analysts expect that Innophos Holdings will post $2.51 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This article was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/08/07/innophos-holdings-inc-nasdaqiphs-rating-lowered-to-sell-at-bidaskclub-updated-updated-updated.html.

Large investors have recently bought and sold shares of the stock. Russell Investments Group Ltd. bought a new stake in shares of Innophos Holdings during the fourth quarter valued at about $882,000. State Street Corp raised its stake in shares of Innophos Holdings by 6.9% in the fourth quarter. State Street Corp now owns 493,747 shares of the specialty chemicals company’s stock valued at $25,808,000 after buying an additional 32,058 shares during the last quarter. FMR LLC raised its stake in shares of Innophos Holdings by 13.3% in the fourth quarter. FMR LLC now owns 193,206 shares of the specialty chemicals company’s stock valued at $10,097,000 after buying an additional 22,612 shares during the last quarter. New York State Teachers Retirement System raised its stake in shares of Innophos Holdings by 10.9% in the fourth quarter. New York State Teachers Retirement System now owns 20,302 shares of the specialty chemicals company’s stock valued at $1,061,000 after buying an additional 2,000 shares during the last quarter. Finally, AQR Capital Management LLC raised its stake in shares of Innophos Holdings by 20.0% in the fourth quarter. AQR Capital Management LLC now owns 123,121 shares of the specialty chemicals company’s stock valued at $6,435,000 after buying an additional 20,482 shares during the last quarter. Hedge funds and other institutional investors own 93.82% of the company’s stock.

Innophos Holdings Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Receive News & Stock Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related stocks with our FREE daily email newsletter.